Chirag Khatiwala | Head of CMC and Technical Operations
Rarity PBC

Chirag Khatiwala, Head of CMC and Technical Operations, Rarity PBC

Biotechnology executive with 20 years of experience driving innovation, regulatory success, and commercialization of advanced therapies. Proven track record leading global CMC, MSAT, and GMP operations across cell therapy, viral vectors, and biologics. Recognized for building high-performing teams, securing IND/BLA approvals, and delivering multi-million-dollar process improvements that accelerate time-to-market and ensure patient access. An effective leader dedicated to empowering and developing personnel, ensuring a culture of growth and excellence.

Appearances:



Advanced Therapies USA 2026 - Day 1 @ 13:10

Chair's Remarks: Chirag Khatiwala, Head of CMC and Technical Operations, Rarity PBC

Advanced Therapies USA 2026 - Day 2 @ 14:05

Panel Discussion: Manufacturing Strategies: Decentralised Vs. Centralised Approaches for Cell Therapies

last published: 05/Mar/26 10:05 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221